Eyepoint Pharmaceuticals Stock Market Value
| EYPT Stock | USD 12.09 0.58 4.58% |
| Symbol | Eyepoint |
Is Eyepoint Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyepoint Pharmaceuticals. If investors know Eyepoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyepoint Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Eyepoint Pharmaceuticals is measured differently than its book value, which is the value of Eyepoint that is recorded on the company's balance sheet. Investors also form their own opinion of Eyepoint Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eyepoint Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyepoint Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eyepoint Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyepoint Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyepoint Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyepoint Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eyepoint Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eyepoint Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eyepoint Pharmaceuticals.
| 02/12/2024 |
| 05/12/2024 |
If you would invest 0.00 in Eyepoint Pharmaceuticals on February 12, 2024 and sell it all today you would earn a total of 0.00 from holding Eyepoint Pharmaceuticals or generate 0.0% return on investment in Eyepoint Pharmaceuticals over 90 days. Eyepoint Pharmaceuticals is related to or competes with Ocuphire Pharma, Reviva Pharmaceuticals, Protalix Biotherapeutics, Sellas Life, Alpha Tau, HCW Biologics, and Innate Pharma. EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatm... More
Eyepoint Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eyepoint Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eyepoint Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 53.79 | |||
| Value At Risk | (6.27) | |||
| Potential Upside | 5.98 |
Eyepoint Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eyepoint Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eyepoint Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eyepoint Pharmaceuticals historical prices to predict the future Eyepoint Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.92) | |||
| Treynor Ratio | 0.9629 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eyepoint Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Eyepoint Pharmaceuticals Backtested Returns
Eyepoint Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.16, which denotes the company had a -0.16% return per unit of risk over the last 3 months. Eyepoint Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eyepoint Pharmaceuticals' Standard Deviation of 6.82, mean deviation of 3.71, and Variance of 46.51 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.16, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Eyepoint Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Eyepoint Pharmaceuticals is expected to outperform it. Eyepoint Pharmaceuticals has an expected return of -1.1%. Please make sure to confirm Eyepoint Pharmaceuticals maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Eyepoint Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.70 |
Good predictability
Eyepoint Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Eyepoint Pharmaceuticals time series from 12th of February 2024 to 28th of March 2024 and 28th of March 2024 to 12th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eyepoint Pharmaceuticals price movement. The serial correlation of 0.7 indicates that around 70.0% of current Eyepoint Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | 0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 12.05 |
Eyepoint Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eyepoint Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eyepoint Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eyepoint Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eyepoint Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eyepoint Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eyepoint Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eyepoint Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eyepoint Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eyepoint Pharmaceuticals Lagged Returns
When evaluating Eyepoint Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eyepoint Pharmaceuticals stock have on its future price. Eyepoint Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eyepoint Pharmaceuticals autocorrelation shows the relationship between Eyepoint Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eyepoint Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Eyepoint Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyepoint Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyepoint Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Eyepoint Stock
| 0.68 | EGRX | Eagle Pharmaceuticals | PairCorr |
Moving against Eyepoint Stock
| 0.66 | ELYM | Eliem Therapeutics Earnings Call Tomorrow | PairCorr |
| 0.63 | VRCA | Verrica Pharmaceuticals Earnings Call Tomorrow | PairCorr |
| 0.42 | YCBD | cbdMD Inc Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to Eyepoint Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyepoint Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyepoint Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyepoint Pharmaceuticals to buy it.
The correlation of Eyepoint Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyepoint Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyepoint Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eyepoint Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Eyepoint Pharmaceuticals Correlation, Eyepoint Pharmaceuticals Volatility and Eyepoint Pharmaceuticals Alpha and Beta module to complement your research on Eyepoint Pharmaceuticals. For more information on how to buy Eyepoint Stock please use our How to Invest in Eyepoint Pharmaceuticals guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Eyepoint Stock analysis
When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Eyepoint Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.